FIELD: organic chemistry, pharmaceuticals.
SUBSTANCE: invention relates to new compounds of formula I , or stereoisomers, or pharmaceutically acceptable salts thereof, wherein Q is SO2; n = 2 or 3; each R1 and R2 is independently H, halogen, OR22 or C1-C6-alkyl; each R3 and R4 is H; each R5 and R6 is independently H or C1-C6-alkyl optionally substituted with phenyl or R5 and R6 together with together with atom to which they are attached may form 5-7-membered ring optionally containing N as the second heteroatom optionally substituted with COOH or C1-C6-alkyl; R7 is H; R7 is optionally substituted 8013-membered bicyclic or tricyclic ring system, containing N in bridge bond and optionally 1, 2 additional heteroatoms selected from N, S wherein substituent represent 1 or 2 halogen atoms; R22 is H or C1-C6-phenyl optionally substituted with C1-C6-alkyl. Compounds of present invention specifically bond to 5-HT6 receptor and are useful in pharmaceutical compositions.
EFFECT: compounds with specific bonding to 5-HT6 receptor.
10 cl, 3 tbl, 45 ex
Title | Year | Author | Number |
---|---|---|---|
1-(AMINOALKYL)-3-SULFONYLAZAINDOLES AS LIGANDS FOR 5-HYDROXYTRYPTAMINE-6 | 2003 |
|
RU2315048C2 |
HETEROCYCLYL-3-SULFONYLINDAZOLES AS 5-HYROXYTRYPTAMINE-6 LIGANDS | 2004 |
|
RU2347780C2 |
DERIVATIVES OF SULFONAMIDE, THEIR PREPARING AND USING AS MEDICAMENTS | 2002 |
|
RU2293082C2 |
INDOLES AS 5-HT MODULATORS | 2007 |
|
RU2449990C2 |
INDOLE DERIVATIVES SHOWING AFFINITY TO 5-HT RECEPTORS | 2002 |
|
RU2294932C2 |
COMPOSITIONS AND METHODS FOR TREATING COGNITIVE DISORDERS | 2005 |
|
RU2420318C2 |
PHENOXYMETHYL HETEROCYCLIC COMPOUNDS | 2009 |
|
RU2531274C2 |
IMIDAZOPYRAZINES AS TYROSINE KINASE INHIBITORS | 2004 |
|
RU2405784C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
LIGANDS OF 5-HT RECEPTORS, PHARMACEUTICAL FORMULATION, PRODUCTION METHOD AND MEDICAL PRODUCT | 2006 |
|
RU2329044C1 |
Authors
Dates
2007-10-27—Published
2002-12-17—Filed